Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 94

1.

Interventions for increasing fruit and vegetable consumption in children aged five years and under.

Hodder RK, O'Brien KM, Stacey FG, Wyse RJ, Clinton-McHarg T, Tzelepis F, James EL, Bartlem KM, Nathan NK, Sutherland R, Robson E, Yoong SL, Wolfenden L.

Cochrane Database Syst Rev. 2018 May 17;5:CD008552. doi: 10.1002/14651858.CD008552.pub5. [Epub ahead of print] Review.

PMID:
29770960
2.

Mitochondrial cyclophilin D regulates T cell metabolic responses and disease tolerance to tuberculosis.

Tzelepis F, Blagih J, Khan N, Gillard J, Mendonca L, Roy DG, Ma EH, Joubert P, Jones RG, Divangahi M.

Sci Immunol. 2018 May 11;3(23). pii: eaar4135. doi: 10.1126/sciimmunol.aar4135.

PMID:
29752301
3.

Integrating smoking cessation care into routine service delivery in a medically supervised injecting facility: An acceptability study.

Skelton E, Tzelepis F, Shakeshaft A, Guillaumier A, Wood W, Jauncey M, Salmon AM, McCrabb S, Palazzi K, Bonevski B.

Addict Behav. 2018 Apr 5;84:193-200. doi: 10.1016/j.addbeh.2018.04.001. [Epub ahead of print]

PMID:
29723802
4.

Quality of Patient-Centered Care Provided to Patients Attending Hematological Cancer Treatment Centers.

Tzelepis F, Clinton-McHarg T, Paul CL, Sanson-Fisher RW, Joshua D, Carey ML.

Int J Environ Res Public Health. 2018 Mar 19;15(3). pii: E549. doi: 10.3390/ijerph15030549.

5.

Prevalence of electronic nicotine delivery systems (ENDS) use among youth globally: a systematic review and meta-analysis of country level data.

Yoong SL, Stockings E, Chai LK, Tzelepis F, Wiggers J, Oldmeadow C, Paul C, Peruga A, Kingsland M, Attia J, Wolfenden L.

Aust N Z J Public Health. 2018 Mar 12. doi: 10.1111/1753-6405.12777. [Epub ahead of print]

PMID:
29528527
6.

Unmet supportive care needs of haematological cancer survivors: rural versus urban residents.

Tzelepis F, Paul CL, Sanson-Fisher RW, Campbell HS, Bradstock K, Carey ML, Williamson A.

Ann Hematol. 2018 Mar 10. doi: 10.1007/s00277-018-3285-x. [Epub ahead of print]

PMID:
29525897
7.

Interventions for increasing fruit and vegetable consumption in children aged five years and under.

Hodder RK, Stacey FG, O'Brien KM, Wyse RJ, Clinton-McHarg T, Tzelepis F, James EL, Bartlem KM, Nathan NK, Sutherland R, Robson E, Yoong SL, Wolfenden L.

Cochrane Database Syst Rev. 2018 Jan 25;1:CD008552. doi: 10.1002/14651858.CD008552.pub4. Review.

PMID:
29365346
8.

BCG Educates Hematopoietic Stem Cells to Generate Protective Innate Immunity against Tuberculosis.

Kaufmann E, Sanz J, Dunn JL, Khan N, Mendonça LE, Pacis A, Tzelepis F, Pernet E, Dumaine A, Grenier JC, Mailhot-Léonard F, Ahmed E, Belle J, Besla R, Mazer B, King IL, Nijnik A, Robbins CS, Barreiro LB, Divangahi M.

Cell. 2018 Jan 11;172(1-2):176-190.e19. doi: 10.1016/j.cell.2017.12.031.

PMID:
29328912
9.

A national study of the unmet needs of support persons of haematological cancer survivors in rural and urban areas of Australia.

Lynagh MC, Williamson A, Bradstock K, Campbell S, Carey M, Paul C, Tzelepis F, Sanson-Fisher R.

Support Care Cancer. 2018 Jun;26(6):1967-1977. doi: 10.1007/s00520-017-4039-3. Epub 2018 Jan 8.

10.

Strategies for enhancing the implementation of school-based policies or practices targeting risk factors for chronic disease.

Wolfenden L, Nathan NK, Sutherland R, Yoong SL, Hodder RK, Wyse RJ, Delaney T, Grady A, Fielding A, Tzelepis F, Clinton-McHarg T, Parmenter B, Butler P, Wiggers J, Bauman A, Milat A, Booth D, Williams CM.

Cochrane Database Syst Rev. 2017 Nov 29;11:CD011677. doi: 10.1002/14651858.CD011677.pub2. Review.

PMID:
29185627
11.

Multi-modal Potentiation of Oncolytic Virotherapy by Vanadium Compounds.

Selman M, Rousso C, Bergeron A, Son HH, Krishnan R, El-Sayes NA, Varette O, Chen A, Le Boeuf F, Tzelepis F, Bell JC, Crans DC, Diallo JS.

Mol Ther. 2018 Jan 3;26(1):56-69. doi: 10.1016/j.ymthe.2017.10.014. Epub 2017 Oct 24.

PMID:
29175158
12.

Interventions for increasing fruit and vegetable consumption in children aged five years and under.

Hodder RK, Stacey FG, Wyse RJ, O'Brien KM, Clinton-McHarg T, Tzelepis F, Nathan NK, James EL, Bartlem KM, Sutherland R, Robson E, Yoong SL, Wolfenden L.

Cochrane Database Syst Rev. 2017 Sep 25;9:CD008552. doi: 10.1002/14651858.CD008552.pub3. Review. Update in: Cochrane Database Syst Rev. 2018 Jan 25;1:CD008552.

PMID:
28945919
13.

Oncolytic Maraba Virus MG1 as a Treatment for Sarcoma.

Le Boeuf F, Selman M, Son HH, Bergeron A, Chen A, Tsang J, Butterwick D, Arulanandam R, Forbes NE, Tzelepis F, Bell JC, Werier J, Abdelbary H, Diallo JS.

Int J Cancer. 2017 Sep 15;141(6):1257-1264. doi: 10.1002/ijc.30813. Epub 2017 Jun 21.

PMID:
28568891
14.

Smoking cessation care provision in Australian alcohol and other drug treatment services: A cross-sectional survey of staff self-reported practices.

Skelton E, Tzelepis F, Shakeshaft A, Guillaumier A, Dunlop A, McCrabb S, Palazzi K, Bonevski B.

J Subst Abuse Treat. 2017 Jun;77:101-106. doi: 10.1016/j.jsat.2017.04.003. Epub 2017 Apr 7.

PMID:
28476261
15.

Addressing tobacco in Australian alcohol and other drug treatment settings: a cross-sectional survey of staff attitudes and perceived barriers.

Skelton E, Tzelepis F, Shakeshaft A, Guillaumier A, Dunlop A, McCrabb S, Palazzi K, Bonevski B.

Subst Abuse Treat Prev Policy. 2017 May 2;12(1):20. doi: 10.1186/s13011-017-0106-5.

16.

Supporting Aboriginal Women to Quit Smoking: Antenatal and Postnatal Care Providers' Confidence, Attitudes, and Practices.

Tzelepis F, Daly J, Dowe S, Bourke A, Gillham K, Freund M.

Nicotine Tob Res. 2017 May 1;19(5):642-646. doi: 10.1093/ntr/ntw286.

PMID:
28403464
17.

Bcl-xL mediates RIPK3-dependent necrosis in M. tuberculosis-infected macrophages.

Zhao X, Khan N, Gan H, Tzelepis F, Nishimura T, Park SY, Divangahi M, Remold HG.

Mucosal Immunol. 2017 Nov;10(6):1553-1568. doi: 10.1038/mi.2017.12. Epub 2017 Apr 12.

18.

Adherence to and factors associated with self-care behaviours in type 2 diabetes patients in Ghana.

Mogre V, Abanga ZO, Tzelepis F, Johnson NA, Paul C.

BMC Endocr Disord. 2017 Mar 24;17(1):20. doi: 10.1186/s12902-017-0169-3.

19.

Adherence to self-care behaviours and associated barriers in type 2 diabetes patients of low-and middle-income countries: a systematic review protocol.

Mogre V, Johnson NA, Tzelepis F, Shaw J, Paul C.

Syst Rev. 2017 Feb 27;6(1):39. doi: 10.1186/s13643-017-0436-4.

20.

A systematic review of eHealth behavioral interventions targeting smoking, nutrition, alcohol, physical activity and/or obesity for young adults.

Oosterveen E, Tzelepis F, Ashton L, Hutchesson MJ.

Prev Med. 2017 Jun;99:197-206. doi: 10.1016/j.ypmed.2017.01.009. Epub 2017 Jan 25. Review.

PMID:
28130046
21.

Intestinal helminth infection impacts the systemic distribution and function of the naive lymphocyte pool.

King IL, Mohrs K, Meli AP, Downey J, Lanthier P, Tzelepis F, Fritz JH, Tumanov AV, Divangahi M, Leadbetter EA, Mohrs M.

Mucosal Immunol. 2017 Sep;10(5):1160-1168. doi: 10.1038/mi.2016.127. Epub 2017 Jan 25.

22.

Quality of patient-centred care: Medical oncology patients' perceptions and characteristics associated with quality of care.

Tzelepis F, Hanna JH, Paul CL, Boyes AW, Carey ML, Regan T.

Psychooncology. 2017 Nov;26(11):1998-2001. doi: 10.1002/pon.4380. Epub 2017 Feb 20. No abstract available.

PMID:
28101971
23.

Tobacco smoking policies in Australian alcohol and other drug treatment services, agreement between staff awareness and the written policy document.

Skelton E, Bonevski B, Tzelepis F, Shakeshaft A, Guillaumier A, Dunlop A, McCrabb S, Palazzi K.

BMC Public Health. 2017 Jan 17;17(1):87. doi: 10.1186/s12889-016-3968-y.

24.

Psychometric properties of implementation measures for public health and community settings and mapping of constructs against the Consolidated Framework for Implementation Research: a systematic review.

Clinton-McHarg T, Yoong SL, Tzelepis F, Regan T, Fielding A, Skelton E, Kingsland M, Ooi JY, Wolfenden L.

Implement Sci. 2016 Nov 8;11(1):148. Review.

25.

Just how high-risk are ongoing smokers? Exploring clusters of health risk behaviours among current and ex-smokers.

Paul C, Tzelepis F, Bisquera A, Noble N, Wiggers J.

Prev Med. 2016 Dec;93:70-75. doi: 10.1016/j.ypmed.2016.09.021. Epub 2016 Sep 24.

PMID:
27670372
26.

How can we help haematological cancer survivors cope with the changes they experience as a result of their cancer?

Hall A, Lynagh M, Tzelepis F, Paul C, Bryant J.

Ann Hematol. 2016 Dec;95(12):2065-2076. Epub 2016 Sep 13.

PMID:
27623627
27.

Strategies to improve the implementation of healthy eating, physical activity and obesity prevention policies, practices or programmes within childcare services.

Wolfenden L, Jones J, Williams CM, Finch M, Wyse RJ, Kingsland M, Tzelepis F, Wiggers J, Williams AJ, Seward K, Small T, Welch V, Booth D, Yoong SL.

Cochrane Database Syst Rev. 2016 Oct 4;10:CD011779. Review.

PMID:
27699761
28.

An organisational change intervention for increasing the delivery of smoking cessation support in addiction treatment centres: study protocol for a randomized controlled trial.

Bonevski B, Guillaumier A, Shakeshaft A, Farrell M, Tzelepis F, Walsberger S, D'Este C, Paul C, Dunlop A, Searles A, Kelly P, Fry R, Stirling R, Fowlie C, Skelton E.

Trials. 2016 Jun 14;17(1):290. doi: 10.1186/s13063-016-1401-6.

29.

Nicotine replacement therapy as a smoking cessation aid among disadvantaged smokers: What answers do we need?

Paul C, Wolfenden L, Tzelepis F, Yoong S, Bowman J, Wye P, Sherwood E, Rose S, Wiggers J.

Drug Alcohol Rev. 2016 Nov;35(6):785-789. doi: 10.1111/dar.12362. Epub 2015 Dec 14.

PMID:
26661119
30.

'The lesser of two evils': A qualitative study of staff and client experiences and beliefs about addressing tobacco in addiction treatment settings.

Wilson AJ, Bonevski B, Dunlop A, Shakeshaft A, Tzelepis F, Walsberger S, Farrell M, Kelly PJ, Guillaumier A.

Drug Alcohol Rev. 2015 Aug 31. doi: 10.1111/dar.12322. [Epub ahead of print]

PMID:
26332170
31.

Improving the continuity of smoking cessation care delivered by quitline services.

Tzelepis F, Paul CL, Knight J, Duncan SL, McElduff P, Wiggers J.

Patient Educ Couns. 2015 Jul 10. pii: S0738-3991(15)30011-2. doi: 10.1016/j.pec.2015.07.004. [Epub ahead of print]

PMID:
26223849
32.

Measuring the quality of patient-centered care: why patient-reported measures are critical to reliable assessment.

Tzelepis F, Sanson-Fisher RW, Zucca AC, Fradgley EA.

Patient Prefer Adherence. 2015 Jun 24;9:831-5. doi: 10.2147/PPA.S81975. eCollection 2015.

33.

Targeting multiple health risk behaviours among vocational education students using electronic feedback and online and telephone support: protocol for a cluster randomised trial.

Tzelepis F, Paul CL, Wiggers J, Kypri K, Bonevski B, McElduff P, Hill MA, Morgan PJ, Lynagh M, Collins CE, Campbell E, Courtney RJ, Chapman K, Wolfenden L, Guillaumier A, Searles A.

BMC Public Health. 2015 Jun 13;15:550. doi: 10.1186/s12889-015-1898-8.

34.

What do haematological cancer survivors want help with? A cross-sectional investigation of unmet supportive care needs.

Hall AE, Sanson-Fisher RW, Lynagh MC, Tzelepis F, D'Este C.

BMC Res Notes. 2015 Jun 6;8:221. doi: 10.1186/s13104-015-1188-7.

35.

Protocol of a multi-centre randomised controlled trial of a web-based information intervention with nurse-delivered telephone support for haematological cancer patients and their support persons.

Bryant J, Sanson-Fisher R, Stevenson W, Smits R, Henskens F, Wei A, Tzelepis F, D'Este C, Paul C, Carey M.

BMC Cancer. 2015 Apr 17;15:295. doi: 10.1186/s12885-015-1314-x.

36.

Development and psychometric evaluation of the Quality of Patient-Centered Cancer Care measure with hematological cancer survivors.

Tzelepis F, Sanson-Fisher RW, Hall AE, Carey ML, Paul CL, Clinton-McHarg T.

Cancer. 2015 Jul 15;121(14):2383-92. doi: 10.1002/cncr.29384. Epub 2015 Apr 15.

37.

Annexin1 regulates DC efferocytosis and cross-presentation during Mycobacterium tuberculosis infection.

Tzelepis F, Verway M, Daoud J, Gillard J, Hassani-Ardakani K, Dunn J, Downey J, Gentile ME, Jaworska J, Sanchez AM, Nédélec Y, Vali H, Tabrizian M, Kristof AS, King IL, Barreiro LB, Divangahi M.

J Clin Invest. 2015 Feb;125(2):752-68. doi: 10.1172/JCI77014. Epub 2014 Dec 22.

38.

The quality of patient-centred care: haematological cancer survivors' perceptions.

Tzelepis F, Sanson-Fisher RW, Hall AE, Carey ML, Paul CL, Clinton-McHarg T.

Psychooncology. 2015 Jul;24(7):796-803. doi: 10.1002/pon.3728. Epub 2014 Dec 11.

PMID:
25504965
39.

The Survivor Unmet Needs Survey (SUNS) for haematological cancer survivors: a cross-sectional study assessing the relevance and psychometric properties.

Hall A, D'Este C, Tzelepis F, Sanson-Fisher R, Lynagh M.

BMC Health Serv Res. 2014 May 9;14:211. doi: 10.1186/1472-6963-14-211.

40.

Anxiety and depression among haematological cancer patients attending treatment centres: prevalence and predictors.

Clinton-McHarg T, Carey M, Sanson-Fisher R, Tzelepis F, Bryant J, Williamson A.

J Affect Disord. 2014 Aug;165:176-81. doi: 10.1016/j.jad.2014.04.072. Epub 2014 May 4.

PMID:
24882197
41.

Factors associated with haematological cancer survivors experiencing a high level of unmet need across multiple items of supportive care: a cross-sectional survey study.

Hall A, D'Este C, Tzelepis F, Lynagh M, Sanson-Fisher R.

Support Care Cancer. 2014 Nov;22(11):2899-909. doi: 10.1007/s00520-014-2264-6. Epub 2014 May 15.

PMID:
24828759
42.

NLRX1 prevents mitochondrial induced apoptosis and enhances macrophage antiviral immunity by interacting with influenza virus PB1-F2 protein.

Jaworska J, Coulombe F, Downey J, Tzelepis F, Shalaby K, Tattoli I, Berube J, Rousseau S, Martin JG, Girardin SE, McCullers JA, Divangahi M.

Proc Natl Acad Sci U S A. 2014 May 20;111(20):E2110-9. doi: 10.1073/pnas.1322118111. Epub 2014 May 5.

43.

Targeted prostaglandin E2 inhibition enhances antiviral immunity through induction of type I interferon and apoptosis in macrophages.

Coulombe F, Jaworska J, Verway M, Tzelepis F, Massoud A, Gillard J, Wong G, Kobinger G, Xing Z, Couture C, Joubert P, Fritz JH, Powell WS, Divangahi M.

Immunity. 2014 Apr 17;40(4):554-68. doi: 10.1016/j.immuni.2014.02.013. Epub 2014 Apr 10.

44.

Tailored and integrated Web-based tools for improving psychosocial outcomes of cancer patients: the DoTTI development framework.

Smits R, Bryant J, Sanson-Fisher R, Tzelepis F, Henskens F, Paul C, Stevenson W.

J Med Internet Res. 2014 Mar 14;16(3):e76. doi: 10.2196/jmir.2849.

45.

Are we missing the Institute of Medicine's mark? A systematic review of patient-reported outcome measures assessing quality of patient-centred cancer care.

Tzelepis F, Rose SK, Sanson-Fisher RW, Clinton-McHarg T, Carey ML, Paul CL.

BMC Cancer. 2014 Jan 25;14:41. doi: 10.1186/1471-2407-14-41. Review.

46.

Implementation of a personalized workplace smoking cessation programme.

Paul CL, McLennan J, Baxendale A, Schnelle B, Rawson J, Turon HE, Tzelepis F.

Occup Med (Lond). 2013 Dec;63(8):568-74. doi: 10.1093/occmed/kqt121. Epub 2013 Nov 7.

PMID:
24213092
47.

Who enrolled in a randomized controlled trial of quitline support? Comparison of participants versus nonparticipants.

Tzelepis F, Paul CL, Walsh RA, Knight J, Wiggers J.

Nicotine Tob Res. 2013 Dec;15(12):2107-13. doi: 10.1093/ntr/ntt114. Epub 2013 Aug 3.

PMID:
23911847
48.

Intrinsic role of FoxO3a in the development of CD8+ T cell memory.

Tzelepis F, Joseph J, Haddad EK, Maclean S, Dudani R, Agenes F, Peng SL, Sekaly RP, Sad S.

J Immunol. 2013 Feb 1;190(3):1066-75. doi: 10.4049/jimmunol.1200639. Epub 2012 Dec 31.

49.

Modulation of antigenic location converts chronic into acute infection by forcing CD8+ T cell recognition.

Tzelepis F, Alcon V, Dudani R, Gurnani K, Zafer A, Everson ES, Young KG, Rüssmann H, Krishnan L, Sad S.

Cell Rep. 2012 Dec 27;2(6):1710-21. doi: 10.1016/j.celrep.2012.10.024. Epub 2012 Dec 6.

50.

Smoking prevalence, attitudes, and confidence about tobacco roles among Australian nursing students.

Walsh RA, Cholowski K, Tzelepis F, Stojanovski E.

J Addict Nurs. 2012 Oct;23(3):181-90. doi: 10.1097/JAN.0b013e31826f4b83.

PMID:
24335735

Supplemental Content

Loading ...
Support Center